NCT02978326 A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression Status COMPLETED Phase PHASE3
NCT02959658 Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT02957617 Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 Status TERMINATED Phase PHASE2
NCT02956486 A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02935608 Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy Status COMPLETED Phase PHASE2
NCT02917187 A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia Status COMPLETED Phase PHASE2
NCT02881567 Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab Status TERMINATED Phase PHASE3
NCT02865109 Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA) Status NO_LONGER_AVAILABLE Phase N/A
NCT02855411 A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) Status TERMINATED Phase PHASE2
NCT02847598 Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT02833142 Pharmacokinetics, Safety and Tolerability of Single Doses of BIIB033 (Opicinumab) Produced by 2 Manufacturing Processes Status COMPLETED Phase PHASE1
NCT02831517 PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants Status COMPLETED Phase PHASE1
NCT02829541 A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants Status COMPLETED Phase PHASE1
NCT02796222 Factor Product Utilization and Health Outcomes in Patients With Hemophilia Status COMPLETED Phase N/A
NCT02782975 Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants Status COMPLETED Phase PHASE1
NCT02778438 A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits Status COMPLETED Phase N/A